Lore Gruenbaum, Chief Scientific Officer at Blood Cancer United, shared on LinkedIn:
“Our Career Development Program is now open for the 2026/2027 application cycle! This program is designed to provide salary support for scientists who conduct basic, translational, or clinical research on hematologic malignancies and relevant premalignant conditions.
We welcome applications worldwide from appropriate non-profit academic institutions and investigators of any nationality. Non-US citizens and non-US residents are eligible.
This program comprises four award categories for postdoctoral researchers with different levels of experience and emerging leaders in basic and clinical research.”
Other articles about Blood Cancer United on OncoDaily.